Shaurav Bhattacharyya: Honoring the 2026 Lasker Award Winners
Shaurav Bhattacharyya, Data Analytics and AI-driven Projects Specialist, shared a post on LinkedIn:
The 2026 Lasker Awards recognize researchers and advocates whose work has contributed to major advances in narcolepsy, hemophilia A, and Parkinson’s disease.
Research on orexin helped reveal the biological mechanisms underlying narcolepsy and opened new therapeutic possibilities.
Research leading to emicizumab introduced an innovative antibody-based approach to treating hemophilia A.
The Michael J. Fox Foundation has helped accelerate Parkinson’s research and strengthen patient involvement in the scientific process.
These achievements highlight how fundamental research, technological innovation, and patient-focused research can translate into meaningful advances in medicine.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke